ULAB03012 / LEO / Richard Burack
Lead Researcher: Walter Burack
The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000 non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and other exposures), host genetic, tumor, and treatment factors, as well as the interaction among these factors, on short and long-term outcomes. These efforts will identify new approaches to improve the survival and well-being of NHL patients.
More Details:
Eligibility:
Inclusion Criteria: * Newly diagnosed non-Hodgkin Lymphoma (NHL), within 183 days of enrollment * Patients may have been treated as long as initial NHL diagnosis is within 6 months of enrollment * 18 years of age or older Exclusion Criteria: * Lymphoma diagnosis greater than 184 days from date of consent